1. Public education on childhood poisoning needed

   Clinical study 17 January 2013 Pages: 2 - 2

2. Superior safety with Advantan (Rm)

   Incidence study 17 January 2013 Pages: 2 - 2

3. Advise potential HRT recipients of breast cancer risk

   Correspondence 17 January 2013 Pages: 3 - 3

4. Antihistamine interactions highlight need for premarketing investigation

   Comment 17 January 2013 Pages: 3 - 3

5. Low toxicity with liposomal encapsulated doxorubicin (Doxil®).

   Correspondence 17 January 2013 Pages: 3 - 3

6. Potential cadaveric growth hormone users should be warned

   Correspondence 17 January 2013 Pages: 3 - 3

7. Acebutolol overdose

   Case report 17 January 2013 Pages: 4 - 4

8. Adenosine

   Case report 17 January 2013 Pages: 4 - 4

9. Overview of antipsychotic drug interactions

   Review 17 January 2013 Pages: 4 - 4

10. Alfacalcidol

    Case reports 17 January 2013 Pages: 5 - 5

11. Amiodarone

    Case report 17 January 2013 Pages: 5 - 5

12. Amiodarone

    Case report 17 January 2013 Pages: 5 - 5

13. Antidepressants

    Case reports 17 January 2013 Pages: 5 - 5

14. Antineoplastics

    Incidence study 17 January 2013 Pages: 5 - 5

15. Antineoplastics

    Case report 17 January 2013 Pages: 6 - 6

16. Antineoplastics

    Case report 17 January 2013 Pages: 6 - 6

17. BCG

    Case report 17 January 2013 Pages: 6 - 6

18. Beta blockers

    Case report 17 January 2013 Pages: 6 - 6

19. Budesonide

    Case report 17 January 2013 Pages: 6 - 6

20. Chloroquine

    Case reports 17 January 2013 Pages: 6 - 6

21. Chloroquine/hydroxychloroquine

    Incidence study 17 January 2013 Pages: 6 - 6

22. Corticosteroids

    Case report 17 January 2013 Pages: 6 - 6

23. Cyclophosphamide

    Case reports 17 January 2013 Pages: 6 - 6

24. Cyclosporin

    Case report 17 January 2013 Pages: 6 - 6

25. Cyclosporin interaction

    Case report 17 January 2013 Pages: 7 - 7

26. Danazol

    Case report 17 January 2013 Pages: 7 - 7

27. Desipramine

    Case report 17 January 2013 Pages: 7 - 7

28. Diltiazem

    Case report 17 January 2013 Pages: 7 - 7

29. Enalapril/captopril

    Case reports 17 January 2013 Pages: 7 - 7

30. Etizolam withdrawal

    Case report 17 January 2013 Pages: 8 - 8

31. Fosfomycin

    Incidence study 17 January 2013 Pages: 8 - 8

32. Gonadorelin

    Case report 17 January 2013 Pages: 8 - 8

33. Halothane

    Case reports 17 January 2013 Pages: 8 - 8

34. Hydralazine

    Incidence study 17 January 2013 Pages: 8 - 8

35. Ifosfamide

    Incidence study 17 January 2013 Pages: 8 - 8

36. Ifosfamide

    Incidence study 17 January 2013 Pages: 9 - 9

37. Ifosfamide

    Case report 17 January 2013 Pages: 9 - 9

38. Indomethacin

    Incidence study 17 January 2013 Pages: 9 - 9

39. Interleukin 2

    Case report 17 January 2013 Pages: 9 - 9

40. Ketamine

    Case report 17 January 2013 Pages: 9 - 9

41. Lidocaine

    Case report 17 January 2013 Pages: 9 - 9

42. Mefloquine

    Case report 17 January 2013 Pages: 9 - 9

43. Methotrexate + sulfasalazine

    Case report 17 January 2013 Pages: 9 - 9

44. Metoclopramide

    Case reports 17 January 2013 Pages: 10 - 10

45. Minaprine

    Case reports 17 January 2013 Pages: 10 - 10

46. Minocycline

    Case report 17 January 2013 Pages: 10 - 10

47. Nadroparin/furosemide

    Case report 17 January 2013 Pages: 10 - 10

48. Naphazoline

    Case report 17 January 2013 Pages: 10 - 10

49. NSAIDs

    Clinical study 17 January 2013 Pages: 10 - 10

50. NSAIDs

    Incidence study 17 January 2013 Pages: 10 - 10